These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 22955722
1. Australian population cohort study of newly arrived refugee children: how effective is predeparture measles and rubella vaccination? Joshua PR, Smith MM, Koh AS, Woodland LA, Zwi K. Pediatr Infect Dis J; 2013 Feb; 32(2):104-9. PubMed ID: 22955722 [Abstract] [Full Text] [Related]
2. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE. J Infect Dis; 2004 May 01; 189 Suppl 1():S116-22. PubMed ID: 15106100 [Abstract] [Full Text] [Related]
3. Serosurvey of measles, mumps and rubella antibodies in Saudi children. Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA. Saudi Med J; 2005 Oct 01; 26(10):1551-4. PubMed ID: 16228054 [Abstract] [Full Text] [Related]
5. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry. Ramondetti F, Sacco S, Comelli M, Bruno G, Falorni A, Iannilli A, d'Annunzio G, Iafusco D, Songini M, Toni S, Cherubini V, Carle F, RIDI Study Group. Diabet Med; 2012 Jun 01; 29(6):761-6. PubMed ID: 22133003 [Abstract] [Full Text] [Related]
6. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S. Cancer; 2004 Aug 01; 101(3):635-41. PubMed ID: 15274078 [Abstract] [Full Text] [Related]
7. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old]. Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M. An Esp Pediatr; 1987 Jul 01; 27(1):27-31. PubMed ID: 3662251 [Abstract] [Full Text] [Related]
8. Serological survey of measles and rubella immunity in Sydney preschool children. Causer J, Mira M, Karr M, Hueston L, Burgess M, Alperstein G, Fett M, Cunningham A. J Paediatr Child Health; 2000 Oct 01; 36(5):418-21. PubMed ID: 11036793 [Abstract] [Full Text] [Related]
9. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S. Bone Marrow Transplant; 2004 Jun 01; 33(12):1187-90. PubMed ID: 15077129 [Abstract] [Full Text] [Related]
10. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia. Jaber SM. Saudi Med J; 2006 Jan 01; 27(1):63-9. PubMed ID: 16432596 [Abstract] [Full Text] [Related]
11. Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015. Jablonka A, Happle C, Grote U, Schleenvoigt BT, Hampel A, Dopfer C, Hansen G, Schmidt RE, Behrens GM. Infection; 2016 Dec 01; 44(6):781-787. PubMed ID: 27449329 [Abstract] [Full Text] [Related]
12. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Sultana R, Rahman MM, Hassan Z, Hassan MS. Scand J Immunol; 2006 Dec 01; 64(6):684-9. PubMed ID: 17083626 [Abstract] [Full Text] [Related]
13. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age. Yadav S, Thukral R, Chakarvarti A. Indian J Med Res; 2003 Nov 01; 118():183-6. PubMed ID: 14723482 [Abstract] [Full Text] [Related]
14. Prevalence of hepatitis B markers and measles, mumps, and rubella antibodies among Jewish refugees from the former Soviet Union. Hurie MB, Gennis MA, Hernandez LV, Dindzans VJ, Davis JP. JAMA; 2003 Nov 01; 273(12):954-6. PubMed ID: 7884955 [Abstract] [Full Text] [Related]
15. Measles, mumps and rubella: control by vaccination. van Druten JA, de Boo T, Plantinga AD. Dev Biol Stand; 1986 Nov 01; 65():53-63. PubMed ID: 3556777 [Abstract] [Full Text] [Related]
18. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt? Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA. East Mediterr Health J; 2009 Nov 01; 15(1):85-93. PubMed ID: 19469430 [Abstract] [Full Text] [Related]
19. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278 [Abstract] [Full Text] [Related]
20. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes. Saffar MJ, Fathpour GR, Parsaei MR, Ajami A, Khalilian AR, Shojaei J, Saffar H. J Trop Pediatr; 2011 Oct 24; 57(5):347-51. PubMed ID: 21078605 [Abstract] [Full Text] [Related] Page: [Next] [New Search]